Jyong Biotech Ltd (MENS)

May 25, 2026

Jyong Biotech Ltd. (MENS) Shows Resilience: Uptick from Key Support ZonePCR Divergence - Newser

May 25, 2026

May 23, 2026

Jyong Biotech Ltd. (MENS) Gains 3.37% as Technical Support Holds, Resistance in FocusIV Rank - Newser

May 23, 2026

May 22, 2026

Jyong Biotech Ltd. (MENS) Stabilizes Near Key Support After Modest UptickIchimoku TK Cross - Newser

May 22, 2026

May 21, 2026

MENS Stock Price, Quote & Chart | JYONG BIOTECH LTD (NASDAQ:MENS) - ChartMill

May 21, 2026

May 18, 2026

Jyong Biotech Ltd. Files Annual Report on Form 20-F for Fiscal Year 2025 - marketscreener.com

May 18, 2026

May 15, 2026

Jyong Biotech (NASDAQ: MENS) flags Botreso FDA hurdles and $19.4M judgment - Stock Titan

May 15, 2026

May 15, 2026

Jyong Biotech Ltd. Files Annual Report on Form 20-F for Fiscal Year Ended December 31, 2025 - Quiver Quantitative

May 15, 2026

May 15, 2026

Inside Jyong Biotech's 2025 SEC annual report filing for investors - Stock Titan

May 15, 2026

May 11, 2026

What Jyong Biotech (MENS) management focus reveals about priorities (Risk Aversion) 2026-05-11Crowd Sentiment Stocks - Newser

May 11, 2026

Apr 30, 2026

Jyong Biotech Delays Annual 20-F (Yearly Report) - The Globe and Mail

Apr 30, 2026

Apr 28, 2026

Jyong Biotech Updates Market Access Strategy for Innovative Botanical Drugs, Establishing Multiple Competitive Advantages for New Drug Portfolio - The Manila Times

Apr 28, 2026

Apr 28, 2026

Jyong Biotech Updates Market Access Strategy for Innovative - GlobeNewswire

Apr 28, 2026

Apr 27, 2026

Short Interest in Jyong Biotech Ltd. (NASDAQ:MENS) Decreases By 43.2% - MarketBeat

Apr 27, 2026

Apr 24, 2026

CEO-linked entities report 33.34% Jyong Biotech (MENS) stake via trust - Stock Titan

Apr 24, 2026

Apr 22, 2026

Jyong Biotech (MENS) Management Strategy | Q1 2025: Earnings ReportPre Earnings - Cổng thông tin điện tử tỉnh Lào Cai

Apr 22, 2026

Apr 20, 2026

Who Backs Jyong Biotech (MENS) Stock (Risk Aversion) 2026-04-20Investment Picks - Cổng thông tin điện tử tỉnh Lào Cai

Apr 20, 2026

Apr 18, 2026

Ming Tsan Hsu Net Worth (2026) - GuruFocus

Apr 18, 2026

Apr 18, 2026

Pang Chieh Chi Net Worth (2026) - GuruFocus

Apr 18, 2026

Apr 18, 2026

Hung Shu Fan Net Worth (2026) - GuruFocus

Apr 18, 2026

Apr 18, 2026

Feng Lin Hsu Net Worth (2026) - GuruFocus

Apr 18, 2026

Apr 18, 2026

Fu Feng Kuo Net Worth (2026) - GuruFocus

Apr 18, 2026

Apr 17, 2026

Jyong Biotech Ltd. (NASDAQ:MENS) Sees Significant Decrease in Short Interest - MarketBeat

Apr 17, 2026

Apr 14, 2026

Jyong Biotech Ltd. Live Share Prices and Trades. MENS.US Live Streaming Share Prices. - London South East

Apr 14, 2026

Apr 14, 2026

Jyong Biotech (NASDAQ: MENS) CFO ZHANG WEI files initial Form 3 - Stock Titan

Apr 14, 2026

Apr 13, 2026

Wei (vivi) Zhang Net Worth (2026) - GuruFocus

Apr 13, 2026

Apr 11, 2026

MENS Options Volatility — NASDAQ:MENS - TradingView

Apr 11, 2026

Apr 11, 2026

MENS Options Chain — NASDAQ:MENS - TradingView

Apr 11, 2026

Apr 10, 2026

MENS News | JYONG BIOTECH LTD (NASDAQ:MENS) - ChartMill

Apr 10, 2026

Apr 08, 2026

Jyong Biotech (MENS) CEO Kuo reports 25,349,500-share indirect stake on Form 3 - Stock Titan

Apr 08, 2026

Apr 06, 2026

Is Jyong Biotech (MENS) Stock Rebounding | Price at $2.47, Up 0.82%Analyst Upgrade Stocks - Newser

Apr 06, 2026

Apr 04, 2026

MENS PE Ratio & Valuation, Is MENS Overvalued - Intellectia AI

Apr 04, 2026

Apr 01, 2026

Director of Jyong Biotech (MENS) files Form 3 showing 3,000 common shares - Stock Titan

Apr 01, 2026

Apr 01, 2026

Director Hsu Feng-Lin reports 3,000 Jyong Biotech (MENS) shares on Form 3 - Stock Titan

Apr 01, 2026

Apr 01, 2026

Director at Jyong Biotech (MENS) discloses holding 3,000 shares - Stock Titan

Apr 01, 2026

Apr 01, 2026

Jyong Biotech (MENS) director Fan Hung-Shu files initial Form 3 - Stock Titan

Apr 01, 2026

Apr 01, 2026

Jyong Biotech (MENS) director files Form 3 with no insider trades - Stock Titan

Apr 01, 2026

Mar 29, 2026

Jyong Biotech Ltd. (NASDAQ:MENS) Short Interest Down 22.7% in March - Defense World

Mar 29, 2026

Mar 28, 2026

Jyong Biotech Updates the Potential Clinical Benefits and Advantages of Its Plant-Derived Innovative Drug MCS®-2 - The Manila Times

Mar 28, 2026

Mar 27, 2026

Jyong Biotech Updates the Potential Clinical Benefits and Advantages of Its Plant-Derived Innovative Drug MCS-2 - Bitget

Mar 27, 2026

Mar 27, 2026

A plant-based prostate drug finished Phase III trials in the U.S. and Taiwan - Stock Titan

Mar 27, 2026

Mar 16, 2026

Jyong Biotech Ltd PE Ratio (TTM) & PE Ratio (TTM) ChartsMENS - GuruFocus

Mar 16, 2026

Mar 15, 2026

Chinese firm sues Taiwan’s Jyong Biotech Ltd. in Cayman to enforce ¥152M China judgment - OffshoreAlert

Mar 15, 2026

Mar 15, 2026

Jyong Biotech Ltd. (NASDAQ:MENS) Sees Large Decrease in Short Interest - MarketBeat

Mar 15, 2026

Mar 12, 2026

Jyong Biotech 'not aware' of any material information amid share price movement - MSN

Mar 12, 2026

Mar 11, 2026

MENS Earnings History & Surprises | EPS & Revenue Results | JYONG BIOTECH LTD (NASDAQ:MENS) - ChartMill

Mar 11, 2026

Feb 28, 2026

MENS Should I Buy - Intellectia AI

Feb 28, 2026